| Quantitative proteomic analysis of post-translational modifications of human histones HC Beck, EC Nielsen, R Matthiesen, LH Jensen, M Sehested, P Finn, ... Molecular & Cellular Proteomics 5 (7), 1314-1325, 2006 | 233 | 2006 |
| PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab JD Jensen, A Knoop, AV Lænkholm, M Grauslund, MB Jensen, ... Annals of oncology 23 (8), 2034-2042, 2012 | 165 | 2012 |
| ADAM12/Syndecan-4 signaling promotes β1Integrin-dependent cell spreading through protein kinase Cα and RhoA CK Thodeti, R Albrechtsen, M Grauslund, M Asmar, C Larsson, Y Takada, ... Journal of Biological Chemistry 278 (11), 9576-9584, 2003 | 152 | 2003 |
| Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance E Santoni-Rugiu, LC Melchior, EM Urbanska, JN Jakobsen, K de Stricker, ... Cancers 11 (7), 923, 2019 | 151 | 2019 |
| BAP2, a gene encoding a permease for branched-chain amino acids in Saccharomyces cerevisiae M Grauslund, T Didion, MC Kielland-Brandt, HA Andersen Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1269 (3), 275-280, 1995 | 134 | 1995 |
| Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy E Martin, AV Thougaard, M Grauslund, PB Jensen, F Bjorkling, ... Toxicology 255 (1-2), 72-79, 2009 | 120 | 2009 |
| Expression of GUT1, which encodes glycerol kinase in Saccharomyces cerevisiae, is controlled by the positive regulators Adr1p, Ino2p and Ino4p and the negative regulator Opi1p … M Grauslund, JM Lopes, B Rønnow Nucleic acids research 27 (22), 4391-4398, 1999 | 103 | 1999 |
| Amino acids induce expression of BAP2, a branched-chain amino acid permease gene in Saccharomyces cerevisiae T Didion, M Grauslund, MC Kielland-Brandt, HA Andersen Journal of bacteriology 178 (7), 2025-2029, 1996 | 95 | 1996 |
| Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma M Andersen, M Grauslund, J Ravn, JB Sørensen, CB Andersen, ... The Journal of Molecular Diagnostics 16 (4), 418-430, 2014 | 73 | 2014 |
| Carbon source-dependent transcriptional regulation of the mitochondrial glycerol-3-phosphate dehydrogenase gene, GUT2, from Saccharomyces cerevisiae M Grauslund, B Rønnow Canadian journal of microbiology 46 (12), 1096-1100, 2000 | 71 | 2000 |
| Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells M Dejligbjerg, M Grauslund, T Litman, L Collins, X Qian, M Jeffers, ... Molecular cancer 7, 1-12, 2008 | 52 | 2008 |
| Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma L Melchior, M Grauslund, B Bellosillo, C Montagut, E Torres, E Moragón, ... Experimental and Molecular Pathology 99 (3), 485-491, 2015 | 49 | 2015 |
| Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination T Greve, VT Wielenga, M Grauslund, N Sørensen, DB Christiansen, ... European Journal of Cancer 49 (8), 1932-1938, 2013 | 49 | 2013 |
| Methylation-associated silencing of microRNA-126 and its host gene EGFL7 in malignant pleural mesothelioma M Andersen, D Trapani, J Ravn, JB Sørensen, CB Andersen, ... Anticancer research 35 (11), 6223-6229, 2015 | 48 | 2015 |
| Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment JN Jakobsen, E Santoni-Rugiu, M Grauslund, L Melchior, JB Sørensen Oncotarget 9 (40), 26195, 2018 | 42 | 2018 |
| Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma … HH Rossing, M Grauslund, EM Urbanska, LC Melchior, CK Rask, ... BMC research notes 6, 1-8, 2013 | 42 | 2013 |
| Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors LH Jensen, AV Thougaard, M Grauslund, B Søkilde, EV Carstensen, ... Cancer research 65 (16), 7470-7477, 2005 | 41 | 2005 |
| Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed … J Solassol, J Vendrell, B Märkl, C Haas, B Bellosillo, C Montagut, M Smith, ... PLoS One 11 (9), e0163444, 2016 | 37 | 2016 |
| Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing MB Mogensen, M Rossing, O Østrup, PN Larsen, PJ Heiberg Engel, ... BMC cancer 18, 1-13, 2018 | 32 | 2018 |
| The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA S Andreasen, LC Melchior, K Kiss, JA Bishop, E Høgdall, M Grauslund, ... Cancer cytopathology 126 (4), 275-281, 2018 | 32 | 2018 |
